Share-Based Stock Options for Directors
First written in FY2016. 4 of 10 entries say "Restated". Latest entry: FY2026-H1.
10 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The company continues to have no applicable stock option plans, other stock acquisition rights or similar instruments. - FY2024-Q2RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The company continues to have no applicable stock option plans, other stock acquisition rights or similar instruments. - FY2021AchievedAnnual report
「Unexercised balance —」
Of the stock options granted in 2017, 23,000 shares were exercised and 4,000 shares expired, leaving no unexercised balance at the end of the period. - FY2021-Q3RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The company continues to have no applicable stock option plans, other stock acquisition rights or similar instruments. - FY2021-Q2No balance disclosed for stock acquisition rightsAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
An unexercised balance of 27,000 shares was disclosed at the end of the previous consolidated fiscal year, but the status of stock options and other stock acquisition rights in this quarterly report is stated as “There are no applicable items,” and the balance of stock acquisition rights is also zero on the financial statements. - FY2020Partial exercise of existing rightsAnnual report
「Exercised 8,000 Expired 5,000 Unexercised balance 27,000」
Of the existing stock options, 8,000 shares were exercised and 5,000 shares expired during the consolidated fiscal year, leaving an unexercised balance of 27,000 shares. No new issuance policy has been announced. - FY2019DroppedAnnual report
「The company decided to discontinue its existing stock options as stock-based compensation for directors and does not plan to issue any new stock acquisition rights in the form of stock options as stock-based compensation for directors in the future.」
The company indicated a policy of discontinuing its existing stock options as stock-based compensation for directors and not issuing any new options in the future. - FY2017RestatedAnnual report
「The stock options existing during the consolidated fiscal year are covered, and the number of stock options is presented on a share-equivalent basis.」
The 40,000 shares underlying stock options for directors, employees and others approved on 24 February 2017 remained outstanding and unvested. The exercise period is from 14 March 2019 to 13 March 2021. - FY2017-Q2AdvancedAnnual report
「The stock acquisition rights issued during the consolidated second quarter are as follows.」
The company issued 400 stock acquisition rights, representing 40,000 underlying shares, as stock options in the form of stock-based compensation for directors. The exercise period is from 14 March 2019 to 13 March 2021. - FY2016First statedAnnual report
「At the 23rd Annual General Meeting of Shareholders held on 24 February 2017, a resolution was adopted under Article 361 of the Companies Act to allocate, within an annual limit of ¥50 million, stock acquisition rights in the form of stock options as stock-based compensation to the company's directors, excluding directors who are Audit and Supervisory Committee members.」
At a general meeting of shareholders, the company approved a stock-based compensation stock option plan for directors, setting annual and maximum limits on the number of shares to be issued.